Molecular biology of bone remodeling: implications for new therapeutic targets for osteoporosis.
about
Melatonin effects on hard tissues: bone and toothCalcitonin inhibits SDCP-induced osteoclast apoptosis and increases its efficacy in a rat model of osteoporosisEffects of ultrasound on estradiol level, bone mineral density, bone biomechanics and matrix metalloproteinase-13 expression in ovariectomized rabbitsThe combined effects of X-ray radiation and hindlimb suspension on bone loss.Cadmium exposure activates the ERK signaling pathway leading to altered osteoblast gene expression and apoptotic death in Saos-2 cells.Effect of formononetin on mechanical properties and chemical composition of bones in rats with ovariectomy-induced osteoporosis.Current and emerging therapies for the treatment of osteoporosisInterleukin-10 inhibits bone resorption: a potential therapeutic strategy in periodontitis and other bone loss diseases.Emerging therapies for the treatment of osteoporosisCurrent, new and future treatments of osteoporosis.Novel techniques in the development of osteoporosis drug therapy: the osteoclast ruffled-border vacuolar H(+)-ATPase as an emerging target.Emerging therapeutic targets for osteoporosis treatment.Transmembrane protein 173 inhibits RANKL-induced osteoclast differentiation.Osteogenic activity of yellow flag iris (Iris pseudacorus) extract modulating differentiation of osteoblasts and osteoclasts.Per-1 is a specific clock gene regulated by parathyroid hormone (PTH) signaling in osteoblasts and is functional for the transcriptional events induced by PTH.Role of Bone Marrow Stromal Cells in Impaired Bone Repair from BRONJ Osseous Lesions.Local application of an ibandronate/collagen sponge improves femoral fracture healing in ovariectomized rats.Artemisia annua extract prevents ovariectomy-induced bone loss by blocking receptor activator of nuclear factor kappa-B ligand-induced differentiation of osteoclasts.Piroxicam treatment augments bone abnormalities in interleukin-10 knockout mice.Ostericum koreanum Reduces LPS-Induced Bone Loss Through Inhibition of Osteoclastogenesis.
P2860
Q27026104-9C0A1E54-9057-4A21-A82F-8613B8546E6BQ28481154-70A18A1F-C03E-4AD9-902C-2BC200EA2AB1Q30397658-9E6F7A08-DF66-47F6-9274-356D6A5F0CAEQ33907150-5F869FD2-CEF1-48C0-9606-325DC8B4CE29Q35705776-41014C4E-122D-4CD6-A94C-3E80DF475265Q36883244-B8B8DD6D-BC58-432B-990C-2B448771A2C9Q36890431-6DDC3C3C-8809-4402-932C-D4078241929BQ37626939-6F067F76-883B-45EE-82BF-567B64BCC747Q37634780-A3331BD9-E06A-463D-8C3E-2680E3ABDCF3Q37777053-59835D38-0587-4B6B-97D9-CD127F2BBEE7Q38205860-84027F45-29C8-48A6-8312-DF46A1128E9FQ38207147-93724D39-FDA1-48CE-8387-70A13A00BF16Q38904914-037D1C62-DC73-451D-BA38-710E98CF96A5Q39228881-D6CB4AE5-111D-470E-A343-E8E025E8E8E0Q39602506-C1A7D0F8-A2FC-4E2B-AFAF-6070DE4FA7C2Q40443904-20DB10E8-B8BF-4393-99B9-0A6F2A9F91C2Q43419291-4406FB34-2EA8-45DF-9112-55917BBBBF3AQ47166692-A0B28FAB-805A-4B0A-83A5-0B81E8AA9EBEQ50609014-E56D46EB-2255-4C2D-860C-60D5527E763DQ53509790-161EA5F7-CB00-42E6-A0ED-F68ED0D0ADC7
P2860
Molecular biology of bone remodeling: implications for new therapeutic targets for osteoporosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Molecular biology of bone remo ...... utic targets for osteoporosis.
@ast
Molecular biology of bone remo ...... utic targets for osteoporosis.
@en
type
label
Molecular biology of bone remo ...... utic targets for osteoporosis.
@ast
Molecular biology of bone remo ...... utic targets for osteoporosis.
@en
prefLabel
Molecular biology of bone remo ...... utic targets for osteoporosis.
@ast
Molecular biology of bone remo ...... utic targets for osteoporosis.
@en
P2860
P1433
P1476
Molecular biology of bone remo ...... eutic targets for osteoporosis
@en
P2093
J Chris Gallagher
P2860
P304
P356
10.1016/J.MATURITAS.2010.01.002
P50
P577
2010-01-29T00:00:00Z